See the companies making headlines in midday trading: Nvidia — Shares of the AI favorite rose about 2.5% after KeyBanc raised its price target to $180, implying a roughly 40% gain from Monday’s close. The company said demand for Nvidia’s H100 chip “remains strong” even with Blackwell’s imminent launch in the second half of the year. Helen of Troy — The housewares stock fell about 28%, hitting a fresh 52-week low during the session. The company reported a first-quarter fiscal 2025 earnings miss before the bell, earning 99 cents per share, excluding items. Analysts polled by FactSet were expecting earnings of $1.59 per share. The company also lowered its full-year guidance. UiPath — The software stock fell about 7% after the company announced it plans to cut about 10% of its global workforce, with most of the cuts expected to occur by the end of the first quarter of fiscal 2026. The company said this is part of a restructuring plan to manage operating expenses. Jumia Technologies — Shares of the company rose about 30%, hitting a new 52-week high after Benchmark initiated coverage of the stock with a buy rating. The $14 price target implies about 65.5% upside from Monday’s close. The company believes the e-commerce platform is at a turning point, citing the region’s demographic shift and its position as an African leader with tailored services to capture demand as catalysts. Chemours — The chemical company rose about 1% after getting a buy upgrade from a neutral at UBS. The company sees potential for better performance, citing positive demand and price drivers in 2025. BP — Shares of the U.S.-listed oil and gas giant fell 4.8% after the company warned it expects to take a $2 billion impairment charge in the second quarter and expects weak refining margins, which the company said would weigh on its earnings results. Lucid — Shares of the electric vehicle company fell more than 2% after rising about 8% in the previous session. Lucid jumped after the company said it delivered 2,394 vehicles in the second quarter, up 70% year-over-year. Novo Nordisk — The healthcare stock fell about 1.9%. On Monday, a study published in JAMA Internal Medicine found that the active ingredient in Eli Lilly’s Mounjaro and Zepbound — tirzepatide — is more effective at weight loss than semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy. Eli Lilly shares rose about 1.6%. Sony — Shares rose 4.4% after National Amusements, the parent company of Paramount Global, and Skydance Media agreed to merge. CNBC reported that the deal attracted bids from Sony and Apollo. Tesla — Shares of the electric car company rose 3.7%. Morgan Stanley maintained its overweight rating on Tesla, noting that the company’s share of the global battery-electric vehicle market in May was 15%. The stock is on track for a 10th straight day of gains. Corning — The specialty glass maker added nearly 4%. A day earlier, Corning raised its second-quarter core sales forecast to about $3.6 billion, up from its previous forecast of about $3.4 billion. The company also said it expects core earnings per share to be at or slightly above management’s guidance of 42 cents to 46 cents. —CNBC's Yun Lee, Pia Singh, Sarah Min and Darla Mercado contributed to this report.
Trending
- Dexcom Launches Stelo, the First Over-the-Counter Continuous Glucose Monitoring Device
- Stock futures were little changed after the Federal Reserve signaled that an interest rate cut was imminent.
- Tesla's Optimus Faces Human Competition at Robotics Conference in Beijing
- How to Position Yourself for a Global Tech Slowdown, According to Morgan Stanley
- Two big tests are coming that will determine whether last week's stock market excitement was justified.
- How a 'seriously outstanding tax debt' can lead to your passport being revoked
- Hezbollah fires rockets at Israel in revenge for its supreme leader
- Boeing Starliner Returns Empty, NASA Enlists SpaceX to Transport Astronauts
NVDA, GLW, HELE, PATH and more
